Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

39.31
-0.2900-0.73%
Post-market: 39.04-0.2700-0.69%19:30 EDT
Volume:5.99M
Turnover:234.61M
Market Cap:45.80B
PE:65.52
High:39.58
Open:39.50
Low:38.52
Close:39.60
52wk High:40.79
52wk Low:18.83
Shares:1.17B
Float Shares:1.09B
Volume Ratio:1.05
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.91
PE(LYR):32.49

Loading ...

TD Cowen Initiates Teva Pharmaceutical Industries at Buy With $55 Price Target

MT Newswires Live
·
Yesterday

Teva initiated with a Buy at TD Cowen

TIPRANKS
·
Yesterday

Teva, Samsung Bioepis Partner to Develop and Commercialize Biosimilar Candidates

MT Newswires Live
·
Yesterday

Press Release: TAPI (Technology & API Services) Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness

Dow Jones
·
Yesterday

NYSE Order Imbalance 18799.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 30

Teva Reports FDA Approval for Degevma

MT Newswires Live
·
Sep 29

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

TIPRANKS
·
Sep 29

Teva Pharmaceutical's Duvakitug Could be Validated by Merck's Tulisokibart Results, Oppenheimer Says

MT Newswires Live
·
Sep 28

J.P. Morgan Sticks to Their Buy Rating for Teva (TEVA)

TIPRANKS
·
Sep 25

NYSE Order Imbalance 23191.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 25

Teva Releases Q3 2026 Aide Memoire

THOMSON REUTERS
·
Sep 24

Teva Enters Acceleration Phase of Transformation Supported by Multi-Year Launch Cycle, Oppenheimer Says

MT Newswires Live
·
Sep 24

Teva Pharmaceuticals Price Target Announced at $50.00/Share by Oppenheimer

Dow Jones
·
Sep 23

Top Teva Insider Makes Massive Multi-Million Dollar Stock Move

TIPRANKS
·
Sep 23

NYSE Order Imbalance 52798.0 Shares on Buy Side

THOMSON REUTERS
·
Sep 22

Teva presents new new real-world data on uzedy at Psych Congress

TIPRANKS
·
Sep 19

Teva Highlights New Real-World Data Showing Uzedy® (Risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

THOMSON REUTERS
·
Sep 19

Teva Pharmaceutical Announces New Senior Notes Offering

TIPRANKS
·
Sep 17

Movement Alert|Teva Pharmaceutical Rises 5.07% in Regular Trading, Ordinary Shares Begin Direct Trading on NYSE

Market Focus
·
Sep 15

Teva Pharmaceutical Begins Direct Trading of Shares on NYSE

MT Newswires Live
·
Sep 14